Devlin Jodi (CIK 1992151) reported 8 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-03-20). Recent activity: Sell TLSI (1,162 shares), Sell TLSI (1,772 shares), Sell TLSI (273 shares), Buy TLSI (50,000 shares), Buy TLSI (24,131 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-20 | TriSalus Life Sciences, Inc. (TLSI) | Chief of Clinical Operations | Sell | 1,162 | $4,799 |
| 2026-03-20 | TriSalus Life Sciences, Inc. (TLSI) | Chief of Clinical Operations | Sell | 1,772 | $7,247 |
| 2026-03-20 | TriSalus Life Sciences, Inc. (TLSI) | Chief of Clinical Operations | Sell | 273 | $1,125 |
| 2025-11-25 | TriSalus Life Sciences, Inc. (TLSI) | Chief of Clinical Operations | Buy | 50,000 | $0 |
| 2025-05-21 | TriSalus Life Sciences, Inc. (TLSI) | Chief of Clinical Operations | Buy | 24,131 | $124,999 |
| 2025-05-21 | TriSalus Life Sciences, Inc. (TLSI) | Chief of Clinical Operations | Sell | 4,764 | $24,678 |
| 2025-02-19 | TriSalus Life Sciences, Inc. (TLSI) | Chief of Clinical Operations | Buy | 5,272 | $0 |
| 2025-01-29 | TriSalus Life Sciences, Inc. (TLSI) | Chief of COMMERC. OPERATIONS | Buy | 10,625 | $0 |
Source: SEC Form 4 filings · as of 2026-03-20